Macrolide Antibiotics 2002
DOI: 10.1007/978-3-0348-8105-0_1
|View full text |Cite
|
Sign up to set email alerts
|

Introduction to the macrolide antibiotics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 83 publications
0
17
0
Order By: Relevance
“…The first macrolide, erythromycin, was discovered in 1952 and since then macrolides have had an important role in treating infectious diseases (Kirst, 2002). Erythromycin has a moderate spectrum of activity which has been enhanced with the production of the newer semi‐synthetic derivatives such as azithromycin, clarithromycin, and more recently, the ketolides (Kirst, 2002). Macrolides are used to treat acute upper and lower respiratory tract infections due to a variety of Gram‐positive bacteria, Mycoplasma pneumoniae , Chlamydia pneumoniae, Legionella pneumophila, Haemophilus influenzae , Moraxella catarrhalis , skin and soft tissue infections, sexually transmitted diseases caused by Chlamydia trachomatis , Treponema pallidum or Ureaplasma urealyticum , chronic pulmonary infections in cystic fibrosis patients, and diseases caused by Bordetella pertusis , Borrelia burgdorferi , Bartonella henselae , Campylobacter spp., Listeria monocytogenes , Rickettsia spp., Rhodococcus equi , as well as Mycobacterium avium‐intracellulare and other atypical mycobacterium.…”
Section: Introductionmentioning
confidence: 99%
“…The first macrolide, erythromycin, was discovered in 1952 and since then macrolides have had an important role in treating infectious diseases (Kirst, 2002). Erythromycin has a moderate spectrum of activity which has been enhanced with the production of the newer semi‐synthetic derivatives such as azithromycin, clarithromycin, and more recently, the ketolides (Kirst, 2002). Macrolides are used to treat acute upper and lower respiratory tract infections due to a variety of Gram‐positive bacteria, Mycoplasma pneumoniae , Chlamydia pneumoniae, Legionella pneumophila, Haemophilus influenzae , Moraxella catarrhalis , skin and soft tissue infections, sexually transmitted diseases caused by Chlamydia trachomatis , Treponema pallidum or Ureaplasma urealyticum , chronic pulmonary infections in cystic fibrosis patients, and diseases caused by Bordetella pertusis , Borrelia burgdorferi , Bartonella henselae , Campylobacter spp., Listeria monocytogenes , Rickettsia spp., Rhodococcus equi , as well as Mycobacterium avium‐intracellulare and other atypical mycobacterium.…”
Section: Introductionmentioning
confidence: 99%
“…Azithromycin, a semi-synthetic derivative of erythromycin, has a broader spectrum of activity against bacteria than erythromycin, and it is active against Grampositive bacteria, Mycobacterium avium-intracellulare, and some Gram-negative species (Ballow & Amsden 1992, Kirst 2002. Unlike erythromycin, azithromycin may not be administered to food fish.…”
Section: Introductionmentioning
confidence: 99%
“…In captive broodstock programs for endangered stocks of salmon, a percentage of fish are held through the entire life cycle, and the risk of BKD epidemics can be high. In those programs oral or injected macrolides may be administered anytime during growth to maturity.Azithromycin, a semi-synthetic derivative of erythromycin, has a broader spectrum of activity against bacteria than erythromycin, and it is active against Grampositive bacteria, Mycobacterium avium-intracellulare, and some Gram-negative species (Ballow & Amsden 1992, Kirst 2002. Unlike erythromycin, azithromycin may not be administered to food fish.…”
mentioning
confidence: 99%
“…Erythromycin, the first macrolide discovered, was isolated from a culture broth of Saccharopolyspora erythraea in 1952, and is still the most used macrolide today. Since the 1950s, several macrolides have been isolated from culture broths of various different bacteria as well as created semi-synthetically (Kirst, 2001). Macrolides are characterised by a fairly broad spectrum of activity against bacteria.…”
Section: History and Mechanism Of Action Of Macrolide Antibioticsmentioning
confidence: 99%